Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April) (2019) 162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)

Corey C. Foster, Chad G. Rusthoven, David J Sher, Lawrence Feldman, Mary Pasquinelli, Michael T. Spiotto, Matthew Koshy

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the word “survival” was omitted by the publisher from the originally published title. The correct and complete title is, “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis.” The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
JournalLung Cancer
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April) (2019) 162–168](S0169500219303393)(10.1016/j.lungcan.2019.02.023)'. Together they form a unique fingerprint.

  • Cite this